Editas Medicine, Inc. (EDIT) › Net IncomeEditas Medicine, Inc. (EDIT) — Net IncomeAnnual figures by fiscal year, from SEC filings.2014: -$13.69M2015: -$72.90M2016: -$97.18M2017: -$120.32M2018: -$109.95M2019: -$133.75M2020: -$115.98M2021: -$192.50M2022: -$220.43M2023: -$153.22M2024: -$237.09M2025: -$160.06M-$160.06M2014Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025-$160.06M+32.5%2024-$237.09M-54.7%2023-$153.22M+30.5%2022-$220.43M-14.5%2021-$192.50M-66.0%2020-$115.98M+13.3%2019-$133.75M-21.6%2018-$109.95M+8.6%2017-$120.32M-23.8%2016-$97.18M-33.3%2015-$72.90M-432.7%2014-$13.69M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share